Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5836)
All Articles published online
|
Mar 10, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World J Clin Oncol 2012; 3(3): 32-42 [PMID: 22442756 DOI: 10.5306/wjco.v3.i3.32] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v3/i3/32.htm |
| Number | Citing Articles |
| 1 |
Andrea Nicolini, Paola Ferrari, Lucrezia Diodati, Angelo Carpi. Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer. International Journal of Molecular Sciences 2017; 18(11): 2321 doi: 10.3390/ijms18112321
|
| 2 |
Birgit Belter, Cathleen Haase-Kohn, Jens Pietzsch. Cutaneous Melanoma: Etiology and Therapy. 2017; : 39 doi: 10.15586/codon.cutaneousmelanoma.2017.ch3
|
| 3 |
Guendalina Lucarini, Oriana Simonetti, Raffaella Lazzarini, Federica Giantomassi, Gaia Goteri, Annamaria Offidani. Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma. Melanoma Research 2020; 30(5): 433 doi: 10.1097/CMR.0000000000000674
|
| 4 |
María-Luisa Nueda, Ana-Isabel Naranjo, Victoriano Baladrón, Jorge Laborda. The proteins DLK1 and DLK2 modulate NOTCH1-dependent proliferation and oncogenic potential of human SK-MEL-2 melanoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014; 1843(11): 2674 doi: 10.1016/j.bbamcr.2014.07.015
|
| 5 |
Sham S. Kakar, Mariusz Z. Ratajczak, Karen S. Powell, Mana Moghadamfalahi, Donald M. Miller, Surinder K. Batra, Sanjay K. Singh, Deodutta Roy. Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells. PLoS ONE 2014; 9(9): e107596 doi: 10.1371/journal.pone.0107596
|
| 6 |
Tamara García-Salum, Andrea Villablanca, Franziska Matthäus, Andrés Tittarelli, Mauricio Baeza, Cristián Pereda, M. Alejandra Gleisner, Fermín E. González, Mercedes N. López, Jörg D. Hoheisel, Johannes Norgauer, Peter J. Gebicke-Haerter, Flavio Salazar-Onfray. Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy. Oncotarget 2018; 9(24): 17014 doi: 10.18632/oncotarget.24795
|
| 7 |
Zhenhua Ding, Sun Jian, Xuebiao Peng, Yimin Liu, Jianyu Wang, Li Zheng, Chengshan Ou, Yinghui Wang, Weixia Zeng, Meijuan Zhou. Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2. Medicine 2015; 94(33): e1327 doi: 10.1097/MD.0000000000001327
|
| 8 |
Jun Dou, Xiangfeng He, Yurong Liu, Yaqian Wang, Fengshu Zhao, Xiaoying Wang, Dengyu Chen, Fangfang Shi, Jing Wang. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs. Cell Biology International 2014; 38(4): 452 doi: 10.1002/cbin.10223
|
| 9 |
Elsa N Garza-Treviño, Salvador L Said-Fernández, Herminia G Martínez-Rodríguez. Understanding the colon cancer stem cells and perspectives on treatment. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0163-7
|
| 10 |
Nawal Alsadi, Jean-François Mallet, Chantal Matar. miRNA-200b Signature in the Prevention of Skin Cancer Stem Cells by Polyphenol-enriched Blueberry Preparation. Journal of Cancer Prevention 2021; 26(3): 162 doi: 10.15430/JCP.2021.26.3.162
|
| 11 |
Piyu Parth Naik, Luca Falzone. Role of Biomarkers in the Integrated Management of Melanoma. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/6238317
|
| 12 |
Franziska Eckert, Karin Schilbach, Lukas Klumpp, Lilia Bardoscia, Efe Cumhur Sezgin, Matthias Schwab, Daniel Zips, Stephan M. Huber. Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.03018
|
| 13 |
Ao‐Xue Wang, Xiao‐Yi Qi. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma. IUBMB Life 2013; 65(9): 748 doi: 10.1002/iub.1193
|
| 14 |
Peyman Ranji, Tayyebali Salmani Kesejini, Sara Saeedikhoo, Ali Mohammad Alizadeh. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance. Tumor Biology 2016; 37(10): 13059 doi: 10.1007/s13277-016-5294-5
|
| 15 |
Annarosa Arcangeli, Maria Raffaella Romoli, Luca Boni, Gianni Gerlini, Lorenzo Tofani, Carmelo Urso, Lorenzo Borgognoni. High hERG1 expression in advanced melanoma. Melanoma Research 2013; 23(3): 185 doi: 10.1097/CMR.0b013e32835fc6c9
|
| 16 |
Haijiang Qiu, Suirong Yuan, Xiaohe Lu. miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma. Oncology Letters 2016; 12(4): 2301 doi: 10.3892/ol.2016.5002
|
| 17 |
Murielle Mimeault, Surinder K. Batra. Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells. Journal of Cellular and Molecular Medicine 2013; 17(1): 30 doi: 10.1111/jcmm.12004
|
| 18 |
Murielle Mimeault, Surinder K. Batra. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine 2014; 39: 3 doi: 10.1016/j.mam.2013.08.001
|
| 19 |
Shun-Da Du, Yi-Lei Mao, Shao-Hua Li, Xin-Ting Sang, Xin Lu, Yi-Yao Xu, Hai-Feng Xu, Lin Zhao, Chun-Mei Bai, Shou-Xian Zhong, Jie-Fu Huang. Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma. World Journal of Hepatology 2012; 4(11): 305-310 doi: 10.4254/wjh.v4.i11.305
|
| 20 |
Ruiya Li, Lingli Zhang, Lizhou Jia, Yan Duan, Yan Li, Jie Wang, Lidao Bao, Na Sha, Soheil S. Dadras. MicroRNA-143 Targets Syndecan-1 to Repress Cell Growth in Melanoma. PLoS ONE 2014; 9(4): e94855 doi: 10.1371/journal.pone.0094855
|
| 21 |
Faezeh Keyghobadi, Maryam Mehdipour, Vahab Nekoukar, Javad Firouzi, Abolfazl Kheimeh, Fatemeh Nobakht Lahrood, Vajihe Azimian Zavareh, Masoumeh Azimi, Mahsa Mohammadi, Niloofar Sodeifi, Marzieh Ebrahimi. Long-Term Inhibition of Notch in A-375 Melanoma Cells Enhances Tumor Growth Through the Enhancement of AXIN1, CSNK2A3, and CEBPA2 as Intermediate Genes in Wnt and Notch Pathways. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00531
|
| 22 |
Kristine E. Day, Lauren N. Beck, Nicholas L. Deep, Joy Kovar, Kurt R. Zinn, Eben L. Rosenthal. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. The Laryngoscope 2013; 123(11): 2681 doi: 10.1002/lary.24102
|
| 23 |
Cornelia Amalinei, Adriana Grigoraș, Ludmila Lozneanu, Irina-Draga Căruntu, Simona-Eliza Giușcă, Raluca Anca Balan. The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 2022; 58(3): 365 doi: 10.3390/medicina58030365
|
| 24 |
Zhiyun He, Dharmalingam Subramaniam, Zhongtao Zhang, Youcheng Zhang, Shrikant Anant. Honokiol as a Radiosensitizing Agent for Colorectal Cancers. Current Colorectal Cancer Reports 2013; 9(4): 358 doi: 10.1007/s11888-013-0191-4
|
| 25 |
Chaoying Yang, Zhaoxia Xia, Lifei Zhu, Yanchang Li, Zhixin Zheng, Jianying Liang, Liangcai Wu. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R. Cell Cycle 2019; 18(24): 3513 doi: 10.1080/15384101.2019.1690881
|
| 26 |
Murielle Mimeault, Surinder K. Batra. Molecular Biomarkers of Cancer Stem/Progenitor Cells Associated with Progression, Metastases, and Treatment Resistance of Aggressive Cancers. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(2): 234 doi: 10.1158/1055-9965.EPI-13-0785
|
| 27 |
Quan Shi, Qi He, Jing Wei. MicroRNA-342 Prohibits Proliferation and Invasion of Melanoma Cells by Directly Targeting Zinc-Finger E-Box-Binding Homeobox 1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(9): 1447 doi: 10.3727/096504018X15193823766141
|